Sale of 'Deopiryohan Income Protection Insurance'

DB Insurance Obtains 3-Month Exclusive Use Rights for 'Pressure Ulcer Diagnosis Benefit Special Contract' View original image

[Asia Economy Reporter Ki Ha-young] DB Insurance announced on the 15th that it has obtained a 3-month exclusive usage right for the bedsore diagnosis benefit rider included in the 'More Necessary Income Protection Insurance' launched on the 10th of last month.


The New Product Review Committee of the General Insurance Association highly evaluated the bedsore diagnosis benefit rider sold in the More Necessary Income Protection Insurance in terms of originality and usefulness, granting the exclusive usage right. Accordingly, other insurance companies will not be able to develop and sell products similar to the bedsore diagnosis benefit for the next three months.


Since the introduction of the system, DB Insurance has maintained the highest record in the insurance industry by acquiring the 15th exclusive usage right only in long-term insurance.


The bedsore diagnosis benefit, which recently obtained the exclusive usage right, is a rider planned to provide coverage for the increasing elderly customer base. Over the past five years, the number of bedsore patients has increased by 28%, but timely treatment for the elderly is difficult due to the heavy burden on medical personnel and facilities caused by COVID-19, as well as group infections in nursing facilities. If treatment is delayed even slightly, bedsores rapidly progress to necrosis, and when progressing to stage 3 or 4 bedsores, the treatment period takes from six months to one year.



A DB Insurance official said, "Through the development of this bedsore diagnosis benefit, we expect it will greatly help minimize progression to severe diseases by supporting timely treatment," adding, "We will continue to strive for new risk coverage in the future."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing